Continued battle Novo Nordisk has faced numerous legal battles over copycat versions of its more popular weight-loss medication, Wegovy, as well as Ozempic, a GLP-1 approved for patients with Type 2 diabetes

Aqua (Water), Glycerin, Niacinamide, Caprylic/Capric/Succinic Triglyceride, Butylene Glycol, Dicaprylyl Ether, Cetyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Hydrogenated Coco-Glycerides, Lauroyl Lysine, Jojoba Esters, Isostearyl Hydroxystearate, C10-18 Triglycerides, Polyglyceryl-3 Beeswax, Aframomum Angustifolium Seed Extract, Paeonia Lactiflora Root Extract, Lilium Candidum Bulb Extract, Jasminum Officinale (Jasmine) Flower Extract, Ascorbyl Glucoside, Adenosine, Sodium Tocopheryl Phosphate, Palmaria Palmata Extract, Hydrolyzed Soy Protein, Parfum (Fragrance), Stearyl Alcohol, Microcrystalline Cellulose, Xylitol, Chlorphenesin, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Xanthan Gum, Ceramide NP, Sodium Acetylated Hyaluronate, Sodium Surfactin, Cellulose Gum, Sodium Hydroxide, Trisodium Ethylenediamine Disuccinate, Pentaerythrityl Tetra-Di-T-Butyl Hydroxyhydrocinnamate, Sodium Benzoate, Trehalose, Potassium Sorbate, Paeonia Officinalis Flower Extract, Tocopherol, CI 14700 (Red 4), Dimethicone, Caprylyl Glycol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Dimethiconol, Alpha-Isomethyl Ionone, Limonene

Growth Factors (2015) 33(5-6):41929
Coming in on an empty stomach can increase the chance of nausea, particularly with higher-concentration formulas
With its multi-component formulation and stable profile, KLOW is suitable for extended research where consistent performance and combined biological effects are required
PMCID: PMC8995671